Avalo Therapeutics Inc AVTX
NASDAQ · United States · Health Technology
$15.05-0.28 (-1.83%)
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-06 | -0.83 | -0.58 | -42.4% | $0 | — | -2.8%$18.84→$18.32 |
| Q1 2026 | 2026-05-13 | -0.98 | -1.00 | +2.0% | — | — | -4.7%$19.94→$19.01 |
| Q4 2025 | 2026-03-23 | -0.37 | -1.49 | +75.2% | — | — | +0.2%$13.42→$13.45 |
| Q3 2025 | 2025-11-06 | -2.19 | -1.67 | -31.1% | — | — | -8.5%$16.45→$15.05 |
| Q4 2024 | 2025-03-20 | -2.74 | 1.67 | -264.1% | — | — | — |
| Q2 2024 | 2024-08-12 | 4.21 | -6.70 | +162.8% | — | — | — |
| Q1 2024 | 2024-05-13 | -141.00 | -1.18 | -11,849.2% | — | — | — |
| Q4 2023 | 2024-03-29 | -113.04 | -4.80 | -2,255.0% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.